A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM-120 (25, 50, 100 or 200 μg freebase-equivalent) for the treatment of anxiety symptoms in subjects diagnosed with generalized anxiety disorder (GAD).
Epistemonikos ID: 5f6c6ea006fbd16ec31e53020cc19e05c6c10a10
First added on: May 13, 2024